Your Partner of Choice for Carbohydrates.

Dextra will be at Bio 2014

BioWe are pleased to announce that Dextra and New Zealand Pharmaceuticals Ltd will attend BIO 2014 in San Diego, CA, June 23 -26, 2014.

Please arrange to meet us by direct email contact to This email address is being protected from spambots. You need JavaScript enabled to view it., or arrange a meeting with us (NZP-Dextra) in the One on One Partnering Program, to discuss the supply of API cGMP bile acids, nucleosides and carbohydrate derivatives for clinical trials, custom synthesis, blood purification products and glycobiology products.

All preparations can be developed from concept through to Phase II at the Dextra, Reading, UK site and larger scale manufacturing undertaken at NZP. NZP manufactures large volumes of the key bile acid, cholic acid, bile acid derivatives and GMP quality ManNAc.

We are seeking to on-license the Intellectual Property regarding DEX-M74 ManNAc, the drug candidate in development for the orphan genetic disease GNE myopathy and glomerular renal disease.